Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a single spatial experiment.

Whether profiling the genome (DNA), the transcriptome (RNA), the proteome (proteins) or any of the other ‘omes’, “there is nothing more comprehensive than sequencing the whole ome”, says ...

By combining high-throughput imaging and sequencing technologies, it’s now possible to examine the expression of the cancer transcriptome in cancer biopsy samples. “Spatial multi-omics is the ...

View Full Profile. Learn about our Editorial Policies. Spatial transcriptomics is not the only -omic approach to studying the immense complexity of biological systems. Just as in situ ...

Illumina unveils first-of-its-kind spatial transcriptomics technology: San Diego Friday, February 21, 2025, 17:00 Hrs [IST] Illumina, Inc. announced a new spatial technology progr ...

Illumina has announced the development of an advanced spatial transcriptomics technology, with commercial availability ...

Lipinski said: "Large-scale and unbiased whole-transcriptome capture are the ... her research demonstrating how high-resolution spatial sequencing reveals changes in a prostate tumor environment.

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

Broad Institute to collaborate on flagship project tapping Illumina's new spatial technology At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning ...